128 related articles for article (PubMed ID: 26858756)
1. Preoperative Serum Interleukin-6 Is a Potential Prognostic Factor for Colorectal Cancer, including Stage II Patients.
Shiga K; Hara M; Nagasaki T; Sato T; Takahashi H; Sato M; Takeyama H
Gastroenterol Res Pract; 2016; 2016():9701574. PubMed ID: 26858756
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.
Ren J; Xu L; Zhou S; Ouyang J; You W; Sheng N; Yan L; Peng D; Xie L; Wang Z
Front Oncol; 2021; 11():776997. PubMed ID: 34926285
[TBL] [Abstract][Full Text] [Related]
3. Postoperative serum interleukin-6 levels correlate with survival in stage I-III colorectal cancer.
Feng S; Li Z; Liu M; Ye Q; Xue T; Yan B
BMC Gastroenterol; 2023 May; 23(1):156. PubMed ID: 37194025
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Preoperative Serum Carcinoembryonic Antigen Varies with Lymph Node Metastasis Status in Colorectal Cancer.
Jia J; Li M; Teng W; Wang L; Zang W; Xiao J; Chen Y
J Oncol; 2021; 2021():4487988. PubMed ID: 34987578
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer.
Shimura T; Shibata M; Gonda K; Murakami Y; Noda M; Tachibana K; Abe N; Ohtake T
Oncol Lett; 2019 Jun; 17(6):5139-5146. PubMed ID: 31186728
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
9. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
[TBL] [Abstract][Full Text] [Related]
10. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
11. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
[No Abstract] [Full Text] [Related]
12. The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA.
Yuan SQ; Zhou ZW; Wan DS; Chen G; Lu ZH; Wang GQ; Pan ZZ
Ai Zheng; 2008 Jun; 27(6):612-7. PubMed ID: 18570735
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
14. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Giessen-Jung C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Schulz C; Heinemann V; Di Gioia D; Stieber P
Tumour Biol; 2015 Sep; 36(10):7897-906. PubMed ID: 25953265
[TBL] [Abstract][Full Text] [Related]
16. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.
Nikiteas NI; Tzanakis N; Gazouli M; Rallis G; Daniilidis K; Theodoropoulos G; Kostakis A; Peros G
World J Gastroenterol; 2005 Mar; 11(11):1639-43. PubMed ID: 15786541
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of serum IL-23 in colorectal cancer.
Elessawi DF; Alkady MM; Ibrahim IM
Arab J Gastroenterol; 2019 Jun; 20(2):65-68. PubMed ID: 31155425
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
19. Preoperative level of serum amyloid A is superior to C-reactive protein in the prognosis of esophageal squamous cell carcinoma.
Meng YQ; Cao X; Wen ZS; Liu QW; Tan ZH; Duan H; Ma GW; Lin P
Dis Esophagus; 2014; 27(7):670-7. PubMed ID: 24033446
[TBL] [Abstract][Full Text] [Related]
20. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
